Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

San Diego’s Science & Tech Community on the Front Lines of COVID-19 Innovation
Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships and Investor Relations

San Diego’s science and tech community is rising to the occasion to help fight the novel coronavirus. Below is a look at several ongoing efforts by local innovative companies, research institutions, and organizations that are developing test kits, vaccines, ventilators, hand sanitizers, real-time dashboards, and more.Model Medicines harnessing the predictive prowess of its AI Drug Discovery Platform to repurpose FDA approved drugs that may serve as a potential therapeutics to prevent individuals from being infected and/or treat individuals infected with the novel coronavirus.

This article originally appeared on Fresh Brewed Tech, prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.